You are here

  • Home
  • Archive
  • Volume 58, Issue 10
  • Ro/SSA and La/SSB specific IgA autoantibodies in serum of patients with Sjögren’s syndrome and systemic lupus erythematosus

Article info

Article menu
Download PDFPDF
Extended report
Ro/SSA and La/SSB specific IgA autoantibodies in serum of patients with Sjögren’s syndrome and systemic lupus erythematosus

Authors

  • Nader Pourmand aDepartment of Medicine, Rheumatology Unit, Karolinska Institutet, Stockholm, Sweden, bDepartment of Rheumatology, Mälar Hospital, Eskilstuna, Sweden, cCentre for Rheumatology/ Bloomsbury Rheumatology Unit, Department of Medicine, University College London, dDepartment of Laboratory Medicine, Division of Clinical Immunology, Karolinska Institutet, Stockholm, Sweden PubMed articlesGoogle scholar articles
  • Marie Wahren-Herlenius aDepartment of Medicine, Rheumatology Unit, Karolinska Institutet, Stockholm, Sweden, bDepartment of Rheumatology, Mälar Hospital, Eskilstuna, Sweden, cCentre for Rheumatology/ Bloomsbury Rheumatology Unit, Department of Medicine, University College London, dDepartment of Laboratory Medicine, Division of Clinical Immunology, Karolinska Institutet, Stockholm, Sweden PubMed articlesGoogle scholar articles
  • Iva Gunnarsson aDepartment of Medicine, Rheumatology Unit, Karolinska Institutet, Stockholm, Sweden, bDepartment of Rheumatology, Mälar Hospital, Eskilstuna, Sweden, cCentre for Rheumatology/ Bloomsbury Rheumatology Unit, Department of Medicine, University College London, dDepartment of Laboratory Medicine, Division of Clinical Immunology, Karolinska Institutet, Stockholm, Sweden PubMed articlesGoogle scholar articles
  • Elisabet Svenungsson aDepartment of Medicine, Rheumatology Unit, Karolinska Institutet, Stockholm, Sweden, bDepartment of Rheumatology, Mälar Hospital, Eskilstuna, Sweden, cCentre for Rheumatology/ Bloomsbury Rheumatology Unit, Department of Medicine, University College London, dDepartment of Laboratory Medicine, Division of Clinical Immunology, Karolinska Institutet, Stockholm, Sweden PubMed articlesGoogle scholar articles
  • Björn Löfström aDepartment of Medicine, Rheumatology Unit, Karolinska Institutet, Stockholm, Sweden, bDepartment of Rheumatology, Mälar Hospital, Eskilstuna, Sweden, cCentre for Rheumatology/ Bloomsbury Rheumatology Unit, Department of Medicine, University College London, dDepartment of Laboratory Medicine, Division of Clinical Immunology, Karolinska Institutet, Stockholm, Sweden PubMed articlesGoogle scholar articles
  • Yiannakis Ioannou aDepartment of Medicine, Rheumatology Unit, Karolinska Institutet, Stockholm, Sweden, bDepartment of Rheumatology, Mälar Hospital, Eskilstuna, Sweden, cCentre for Rheumatology/ Bloomsbury Rheumatology Unit, Department of Medicine, University College London, dDepartment of Laboratory Medicine, Division of Clinical Immunology, Karolinska Institutet, Stockholm, Sweden PubMed articlesGoogle scholar articles
  • David A Isenberg aDepartment of Medicine, Rheumatology Unit, Karolinska Institutet, Stockholm, Sweden, bDepartment of Rheumatology, Mälar Hospital, Eskilstuna, Sweden, cCentre for Rheumatology/ Bloomsbury Rheumatology Unit, Department of Medicine, University College London, dDepartment of Laboratory Medicine, Division of Clinical Immunology, Karolinska Institutet, Stockholm, Sweden PubMed articlesGoogle scholar articles
  • Carl G M Magnusson aDepartment of Medicine, Rheumatology Unit, Karolinska Institutet, Stockholm, Sweden, bDepartment of Rheumatology, Mälar Hospital, Eskilstuna, Sweden, cCentre for Rheumatology/ Bloomsbury Rheumatology Unit, Department of Medicine, University College London, dDepartment of Laboratory Medicine, Division of Clinical Immunology, Karolinska Institutet, Stockholm, Sweden PubMed articlesGoogle scholar articles
  1. Dr N Pourmand, Department of Medicine, Rheumatology Unit, Centre of Molecular Medicine, Building L8:04, Karolinska Hospital, S-171 76 Stockholm, Sweden.
View Full Text

Citation

Pourmand N, Wahren-Herlenius M, Gunnarsson I, et al
Ro/SSA and La/SSB specific IgA autoantibodies in serum of patients with Sjögren’s syndrome and systemic lupus erythematosus
Annals of the Rheumatic Diseases 1999;58:623-629.

Publication history

  • Accepted May 10, 1999
  • First published October 1, 1999.
Online issue publication 
January 09, 2022

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Copyright information

Annals of the Rheumatic Diseases